Herceptin (Trastuzumab)

Description

Herceptin (Trastuzumab) is a targeted cancer therapy used primarily in HER2-positive breast and gastric cancers. It works by binding to the HER2 protein on cancer cells, helping to slow or stop tumor growth. This medication plays a key role in improving treatment outcomes when used under medical supervision as part of a comprehensive cancer care plan.